Evidence map›Paper›PMID 40520978›Full record

ArticleJAACAP open2025

Clinical Characteristics and Treatment Outcomes of Alcohol Withdrawal Syndrome in Adolescents and Young Adults.

Hayrunnisa Unlu, Asmaa Yehia, Sherif El-Gayar, Amogh Havanur, Farha Deceus, Samantha J Brown, Sarah B Umar, Paul E Croarkin, Terry D Schneekloth, Osama A Abulseoud

Abstract read
In one paragraph

Article in JAACAP open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Age and Sex Differences in Alcohol Withdrawal Syndrome.Mayo Clinic proceedings. Innovations, quality & outcomes · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hayrunnisa UnluMayo Clinic Arizona, Phoenix, Arizona.
Asmaa YehiaMayo Clinic Arizona, Phoenix, Arizona.
Sherif El-GayarAlix School of Medicine at Mayo Clinic, Phoenix, Arizona.
Amogh HavanurMayo Clinic Arizona, Phoenix, Arizona.
Farha DeceusAlix School of Medicine at Mayo Clinic, Phoenix, Arizona.
Samantha J BrownAlix School of Medicine at Mayo Clinic, Phoenix, Arizona.
Sarah B UmarMayo Clinic Arizona, Phoenix, Arizona.
Paul E CroarkinMayo Clinic Rochester, Rochester, Minnesota.
Terry D SchneeklothMayo Clinic Arizona, Phoenix, Arizona.
Osama A AbulseoudMayo Clinic Arizona, Phoenix, Arizona.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Despite the high prevalence of underage drinking, little is known about alcohol withdrawal syndrome (AWS) in adolescents and young adults. The aim of this study is to characterize AWS in this population. Method: We conducted a retrospective chart review of all hospital admissions with the Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-Ar) protocol at Mayo Clinic between June 2019 and June 2022. Results: We identified a total of 10,220 patients with 16,338 hospital admissions where CIWA-Ar protocol was implemented. Within this cohort, 130 patients (70 male and 60 female; 1.3% of all patients) with 148 admissions (0.9% of all admissions) were under 21 years of age. A total of 44% of patients (n = 65) presented with suicidal ideations, and 26% (n = 40) had suicide attempts. In all, 22 (n = 33) required admission to the intensive care unit. The median length of stay in the intensive care unit was 32.8 hours. The median peak CIWA-Ar score was 9 (minimum-maximum = 4-39, interquartile range = 7), and the median time from hospital admission to peak CIWA-Ar score was 9.4 hours (minimum-maximum = 0.1-126, interquartile range = 20.2). A total of 40% of patients (n = 59) received benzodiazepines, whereas 20% (n = 31) required antipsychotics. Three patients (2%) developed delirium tremens, and 5 episodes of alcohol withdrawal seizures (3.4%) were observed. No deaths were reported during hospitalization. However, over the subsequent follow-up period from 2019 to 2023, the all-cause post-hospitalization mortality rate was 3% (n = 4) within 1.6 (±0.6) years. Conclusion: These data suggest that adolescents and young adults presenting for treatment of AWS are at risk for morbidity and mortality due to suicidality and withdrawal complications such as withdrawal seizures and delirium tremens. Further studies should evaluate the underlying social and neurobiological predictors of vulnerability and resilience in this age group.

Indexed as

adolescentsalcohol withdrawal syndromedelirium tremenssubstance misusesuicidality

Identifiers

PMID40520978
PMCPMC12166939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.